162 related articles for article (PubMed ID: 14645245)
21. Amino acids within the extracellular matrix (ECM) binding region (201-218) of rat insulin-like growth factor binding protein (IGFBP)-5 are important determinants in binding IGF-I.
Bramani S; Song H; Beattie J; Tonner E; Flint DJ; Allan GJ
J Mol Endocrinol; 1999 Aug; 23(1):117-23. PubMed ID: 10425523
[TBL] [Abstract][Full Text] [Related]
22. IGF dependent modulation of IGF binding protein (IGFBP) proteolysis by pregnancy-associated plasma protein-A (PAPP-A): multiple PAPP-A-IGFBP interaction sites.
Gaidamauskas E; Gyrup C; Boldt HB; Schack VR; Overgaard MT; Laursen LS; Oxvig C
Biochim Biophys Acta; 2013 Mar; 1830(3):2701-9. PubMed ID: 23671931
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor-binding protein 5 complexes with the acid-labile subunit. Role of the carboxyl-terminal domain.
Twigg SM; Kiefer MC; Zapf J; Baxter RC
J Biol Chem; 1998 Oct; 273(44):28791-8. PubMed ID: 9786878
[TBL] [Abstract][Full Text] [Related]
24. Production of recombinant porcine IGF-binding protein-5 and its effect on proliferation of porcine embryonic myoblast cultures in the presence and absence of IGF-I and Long-R3-IGF-I.
Pampusch MS; Xi G; Kamanga-Sollo E; Loseth KJ; Hathaway MR; Dayton WR; White ME
J Endocrinol; 2005 Apr; 185(1):197-206. PubMed ID: 15817840
[TBL] [Abstract][Full Text] [Related]
25. Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation.
Fowlkes JL; Thrailkill KM; George-Nascimento C; Rosenberg CK; Serra DM
Endocrinology; 1997 Jun; 138(6):2280-5. PubMed ID: 9165012
[TBL] [Abstract][Full Text] [Related]
26. Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: identification of cleavage site and characterization of IGFBP-2 degradation.
Monget P; Mazerbourg S; Delpuech T; Maurel MC; Manière S; Zapf J; Lalmanach G; Oxvig C; Overgaard MT
Biol Reprod; 2003 Jan; 68(1):77-86. PubMed ID: 12493698
[TBL] [Abstract][Full Text] [Related]
27. Heparin binding domain of insulin-like growth factor binding protein-5 stimulates mesangial cell migration.
Abrass CK; Berfield AK; Andress DL
Am J Physiol; 1997 Dec; 273(6):F899-906. PubMed ID: 9435678
[TBL] [Abstract][Full Text] [Related]
28. Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation.
Fogelgren B; Polgár N; Szauter KM; Ujfaludi Z; Laczkó R; Fong KS; Csiszar K
J Biol Chem; 2005 Jul; 280(26):24690-7. PubMed ID: 15843371
[TBL] [Abstract][Full Text] [Related]
29. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
[TBL] [Abstract][Full Text] [Related]
30. The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5.
Zesławski W; Beisel HG; Kamionka M; Kalus W; Engh RA; Huber R; Lang K; Holak TA
EMBO J; 2001 Jul; 20(14):3638-44. PubMed ID: 11447105
[TBL] [Abstract][Full Text] [Related]
31. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation.
Yeh LC; Adamo ML; Olson MS; Lee JC
Endocrinology; 1997 Oct; 138(10):4181-90. PubMed ID: 9322928
[TBL] [Abstract][Full Text] [Related]
32. Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth.
Nam TJ; Busby WH; Rees C; Clemmons DR
Endocrinology; 2000 Mar; 141(3):1100-6. PubMed ID: 10698186
[TBL] [Abstract][Full Text] [Related]
33. Several acidic amino acids in the N-domain of insulin-like growth factor-binding protein-5 are important for its transactivation activity.
Zhao Y; Yin P; Bach LA; Duan C
J Biol Chem; 2006 May; 281(20):14184-91. PubMed ID: 16543235
[TBL] [Abstract][Full Text] [Related]
34. Ras-association domain family 1 protein, RASSF1C, is an IGFBP-5 binding partner and a potential regulator of osteoblast cell proliferation.
Amaar YG; Baylink DJ; Mohan S
J Bone Miner Res; 2005 Aug; 20(8):1430-9. PubMed ID: 16007340
[TBL] [Abstract][Full Text] [Related]
35. Effects of IGFBP-1 and IGFBP-2 and their fragments on migration and IGF-induced proliferation of human dermal fibroblasts.
Brandt K; Grünler J; Brismar K; Wang J
Growth Horm IGF Res; 2015 Feb; 25(1):34-40. PubMed ID: 25468444
[TBL] [Abstract][Full Text] [Related]
36. Insulin-like growth factor (IGF)-I stimulates cell proliferation and induces IGF binding protein (IGFBP)-3 and IGFBP-5 gene expression in cultured growth plate chondrocytes via distinct signaling pathways.
Kiepe D; Ciarmatori S; Hoeflich A; Wolf E; Tönshoff B
Endocrinology; 2005 Jul; 146(7):3096-104. PubMed ID: 15845624
[TBL] [Abstract][Full Text] [Related]
37. Cumulative mutagenesis of the basic residues in the 201-218 region of insulin-like growth factor (IGF)-binding protein-5 results in progressive loss of both IGF-I binding and inhibition of IGF-I biological action.
Allan GJ; Tonner E; Szymanowska M; Shand JH; Kelly SM; Phillips K; Clegg RA; Gow IF; Beattie J; Flint DJ
Endocrinology; 2006 Jan; 147(1):338-49. PubMed ID: 16195401
[TBL] [Abstract][Full Text] [Related]
38. Differential gene expression in premalignant human trophoblast: role of IGFBP-5.
Lee BP; Rushlow WJ; Chakraborty C; Lala PK
Int J Cancer; 2001 Dec; 94(5):674-84. PubMed ID: 11745462
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
[TBL] [Abstract][Full Text] [Related]
40. Ribonucleic acid polymerase II binding subunit 3 (Rpb3), a potential nuclear target of insulin-like growth factor binding protein-3.
Oufattole M; Lin SW; Liu B; Mascarenhas D; Cohen P; Rodgers BD
Endocrinology; 2006 May; 147(5):2138-46. PubMed ID: 16455777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
